InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MCGRAW BENJAMIN F III, Director. Director active across 1 companies, notably Aerie Pharmaceuticals INC. Aggregated, 6 reports have been recorded. The latest transaction was filed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
06,245 shares0
Common Stock
SEC:0001209191-22-036397:0·
€76,63810,324 shares@ €7.4233100.0% of flow
Common Stock
SEC:0001209191-22-014974:0·
034,513 shares0
Common Stock
SEC:0001209191-21-057288·
034,513 shares0
Common Stock
SEC:0001209191-21-057288:0·
01,750 shares0
Common Stock
SEC:0001209191-21-042031·
01,750 shares0
Common Stock
SEC:0001209191-21-042031:0·
6 of 6 declarations
About MCGRAW BENJAMIN F III
Benjamin F. McGraw III is a Board Member and Interim Executive Chairman at AERIE PHARMACEUTICALS INC. He plays a key role in the governance of the company, participating in strategic decision-making and guiding operations. His experience in the pharmaceutical sector is valuable to the board, allowing AERIE to focus on innovation and growth.
